Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Noble Roman's, Inc.

NROMPNK
$0.38
$0.02(5.56%)
U.S. Market is Open • 15:02

Noble Roman's, Inc. Fundamental Analysis

Noble Roman's, Inc. (NROM) shows moderate financial fundamentals with a PE ratio of 8.44, profit margin of 6.21%, and ROE of 36.45%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 5.40%.

Key Strengths

ROE36.45%
PEG Ratio0.09

Areas of Concern

Current Ratio0.40
We analyze NROM's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 32.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
32.1/100

We analyze NROM's fundamental strength across five key dimensions:

Efficiency Score

Weak

NROM struggles to generate sufficient returns from assets.

ROA > 10%
6.06%

Valuation Score

Excellent

NROM trades at attractive valuation levels.

PE < 25
8.44
PEG Ratio < 2
0.09

Growth Score

Moderate

NROM shows steady but slowing expansion.

Revenue Growth > 5%
5.40%
EPS Growth > 10%
-1.00%

Financial Health Score

Weak

NROM carries high financial risk with limited liquidity.

Debt/Equity < 1
3.78
Current Ratio > 1
0.40

Profitability Score

Moderate

NROM maintains healthy but balanced margins.

ROE > 15%
36.45%
Net Margin ≥ 15%
6.21%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is NROM Expensive or Cheap?

P/E Ratio

NROM trades at 8.44 times earnings. This suggests potential undervaluation.

8.44

PEG Ratio

When adjusting for growth, NROM's PEG of 0.09 indicates potential undervaluation.

0.09

Price to Book

The market values Noble Roman's, Inc. at 2.43 times its book value. This may indicate undervaluation.

2.43

EV/EBITDA

Enterprise value stands at -1.16 times EBITDA. This is generally considered low.

-1.16

How Well Does NROM Make Money?

Net Profit Margin

For every $100 in sales, Noble Roman's, Inc. keeps $6.21 as profit after all expenses.

6.21%

Operating Margin

Core operations generate 14.68 in profit for every $100 in revenue, before interest and taxes.

14.68%

ROE

Management delivers $36.45 in profit for every $100 of shareholder equity.

36.45%

ROA

Noble Roman's, Inc. generates $6.06 in profit for every $100 in assets, demonstrating efficient asset deployment.

6.06%

Following the Money - Real Cash Generation

Operating Cash Flow

Noble Roman's, Inc. generates limited operating cash flow of $1.32M, signaling weaker underlying cash strength.

$1.32M

Free Cash Flow

Noble Roman's, Inc. produces free cash flow of $1.18M, offering steady but limited capital for shareholder returns and expansion.

$1.18M

FCF Per Share

Each share generates $0.05 in free cash annually.

$0.05

FCF Yield

NROM converts 14.36% of its market value into free cash.

14.36%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

8.44

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.43

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.52

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

3.78

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.40

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.36

vs 25 benchmark

ROA

Return on assets percentage

0.06

vs 25 benchmark

ROCE

Return on capital employed

0.29

vs 25 benchmark

How NROM Stacks Against Its Sector Peers

MetricNROM ValueSector AveragePerformance
P/E Ratio8.4424.93 Better (Cheaper)
ROE36.45%1149.00% Weak
Net Margin6.21%749.00% Weak
Debt/Equity3.780.76 Weak (High Leverage)
Current Ratio0.409.21 Weak Liquidity
ROA6.06%1274.00% Weak

NROM outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Noble Roman's, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

35.84%

Industry Style: Cyclical, Growth, Discretionary

High Growth

EPS CAGR

99.12%

Industry Style: Cyclical, Growth, Discretionary

High Growth

FCF CAGR

-37.59%

Industry Style: Cyclical, Growth, Discretionary

Declining

Fundamental Analysis FAQ